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Background: Bronchopulmonary dysplasia is a chronic lung disease of premature neonates characterized by
arrested pulmonary alveolar development. There is increasing evidence that microRNAs (miRNAs) regulate
translation of messenger RNAs (mRNAs) during lung organogenesis. The potential role of miRNAs in the
pathogenesis of BPD is unclear.
Results: Following exposure of neonatal mice to 80% O2 or room air (RA) for either 14 or 29 days, lungs of
hyperoxic mice displayed histological changes consistent with BPD. Comprehensive miRNA and mRNA profiling
was performed using lung tissue from both O2 and RA treated mice, identifying a number of dynamically regulated
miRNAs and associated mRNA target genes. Gene ontology enrichment and pathway analysis revealed that
hyperoxia modulated genes involved in a variety of lung developmental processes, including cell cycle, cell
adhesion, mobility and taxis, inflammation, and angiogenesis. MiR-29 was prominently increased in the lungs of
hyperoxic mice, and several predicted mRNA targets of miR-29 were validated with real-time PCR, western blotting
and immunohistochemistry. Direct miR-29 targets were further validated in vitro using bronchoalveolar stem cells.
Conclusion: In newborn mice, prolonged hyperoxia induces an arrest of alveolar development similar to that seen
in human neonates with BPD. This abnormal lung development is accompanied by significant increases in the
levels of multiple miRNAs and corresponding decreases in the levels of predicted mRNA targets, many of which
have known or suspected roles in pathways altered in BPD. These data support the hypothesis that dynamic
regulation of miRNAs plays a prominent role in the pathophysiology of BPD.Background
Bronchopulmonary dysplasia (BPD) was first described in
1967 by Northway et al., who hypothesized that its patho-
genesis stemmed from prolonged mechanical ventilation of
the surfactant-deficient lung with high concentrations of
inspired oxygen (hyperoxia) [1]. Since then, new therapies
and advances in ventilatory management have led to the
disappearance of the “classic” or “old” BPD lesions
described in that landmark study. In the present era, BPD
most often affects only extremely premature infants born* Correspondence: wigle.dennis@mayo.edu
1Division of General Thoracic Surgery, Department of Surgery, Mayo Clinic,
Rochester, MN, USA
5Department of Physiology and Biomedical Engineering, Mayo Clinic,
Rochester, MN, USA
Full list of author information is available at the end of the article
© 2012 Dong et al.; licensee BioMed Central L
Commons Attribution License (http://creativec
reproduction in any medium, provided the orbetween 23 and 28 weeks gestation [2]. This “left-shift” in
the gestational age of the affected population, during which
time critical events in lung development are occurring, has
required a profound change in our investigation and under-
standing of both the histopathology and pathophysiology of
BPD.
The developing human lung undergoes a well-
described series of morphologic changes, each of which
occurs within a discrete period of embryonic and fetal
development. It is not until the saccular stage, which
begins at 24–26 weeks gestation, that pulmonary alveoli
begin to form [3]. The lung of an extremely premature
neonate consists of abnormal interstitium, an epithelium
with few alveoli-forming secondary crests, an immature
pattern of elastin deposition and an incompletely devel-
oped vasculature. Interestingly, these histologicaltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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long-term mechanical ventilation after delivery at an ex-
tremely premature gestational age. This so-called arrest
of alveolar development defines the modern-day or
“new” BPD [4].
Currently little is known about the molecular and cellular
basis of BPD [2,4,5]. This may be due, in part, to the com-
plexity and prohibitive expense of traditional animal models
of newborn lung injury, such as prolonged mechanical ven-
tilation of premature baboons or lambs [4,6]. In this regard,
the murine hyperoxia model may provide an ideal alterna-
tive to study the pathologic arrest of alveolar development
in BPD. Recent research has shown that exposing newborn
mice to high concentrations of ambient oxygen recapitu-
lates the histopathology of BPD [7-9]. This is an important
finding, as the lungs of mice born naturally at term have
reached the same developmental stage as those of the ex-
tremely premature human neonate [7,10]. Furthermore,
current technologies have greatly facilitated generation and
availability of genetically engineered mouse strains that will
allow dissection of molecular pathways in BPD.
Alveolar development is a complex process involving
multiple mechanisms relating to cell cycle, cell adhesion,
mobility and taxis, and angiogenesis. Recent work by our
group has demonstrated the dynamic regulation of micro-
RNAs (miRNAs) during lung organogenesis [11]. MiRNAs
are a class of small non-coding RNA that regulate gene
expression either by inhibiting protein translation or by
cleavage of mRNA targets based on the pairing of miRNAs
and their mRNA target binding sites [12]. Individual
miRNA may target multiple mRNAs, and individual mRNA
may contain sequences complementary to multiple miRNA
family members [13,14]. It is estimated that miRNAs may
be responsible for regulating the expression of nearly one-
third of the human genome [15]. MiRNAs are known to
play multiple roles in organ development, carcinogenesis,
and immune responses [16,17], and have been implicated
in many critical cellular processes, including apoptosis, pro-
liferation, and differentiation [18]. Despite the identification
of more than 800 mature human miRNAs and 700 mouse
miRNAs, much remains to be discovered about their func-
tional targets and biologic role.
In the current study, we explored the regulation of miR-
NAs and corresponding target mRNAs during the arrest of
alveolar development prominent in a murine model of
BPD. We provide evidence that dynamic regulation of miR-
NAs may play a prominent role in the pathophysiology of
BPD.
Results
Prolonged hyperoxia impairs somatic growth and lung
development in neonatalmice
Each of the experimental groups were comprised of 11
mice, all of which survived their respective exposureperiods. The 14 and 29 day time points were chosen to
capture a cross section of hyperoxic exposure during alveo-
lar development in the mouse. Among mice exposed to
prolonged hyperoxia, both somatic growth and lung devel-
opment were reduced in comparison to room air-exposed
controls. The body weight of O2 mice was slightly lower
than that of normoxic mice after 14 days of exposure, but
was markedly lower after 29 days of exposure (not shown).
Prolonged hyperoxia caused substantial alterations in
lung morphology. After 14 days of exposure, the lungs of
O2 mice contained fewer alveoli than those of RA mice,
with generalized enlargement of alveolar airspaces. These
histological changes were even more pronounced after
29 days of exposure, with little or no morphologic matur-
ation seen in the lungs of O2 mice. On average, compared
with normoxic mice, Mean linear intercept (MLI; which
represents the average alveolar diameter) was increased by
66% and 93% after 14 and 29 days of hyperoxic exposure,
respectively. Alveolar septal thickness (AST) was increased
by 50% and 73% for the same groups, respectively
(Figure 1A-F). Gene expressions of several well-known
BPD biomarkers were measured by Real-time PCR. Trans-
forming growth factor (TGF)-β signaling is involved in pul-
monary fibrosis and inhibition of branching morphogenesis
in lung development [19]. TGF-β mRNA was increased 4.2
fold in hyperoxia-induced BPD mice. Fibronectin 1, a com-
ponent of the extracellular matrix [20], was also increased
4.5 fold at day 29. Vascular endothelial growth factor
(VEGF)-α is an endothelial cell mitogen that regulates
endothelial cell differentiation and angiogenesis [21], with
expression decreased by 65% after hyperoxia. Insulin-like
growth factor (IGF)-1 was dramatically increased by 10.2
fold in the lung of O2 treated adult mice. IGF has been
shown to be a strong profibrogenic mediator, acting as a
potent mitogen and stimulator of collagen synthesis [22].
The expression of p21 was increased 6.2 fold, indicating
hyperoxia can cause proliferation arrest of cells in the lung
[23] (Figure 1G). Taken together, these biomarker changes,
accompanied by pulmonary morphological changes, are
consistent with development of human BPD.
Prolonged hyperoxia alters mRNA expression in the
neonatal mouse lung
To investigate genes dynamically regulated as a conse-
quence of hyperoxia, mRNA expression profiling was
performed using the Affymetrix GeneChip Mouse Genome
430 2.0 array. In total, 12 samples were used for mRNA
profiling, 2 samples for each normoxia group at time points
of P1, P14, and P29; and 3 samples for each hyperoxia-
treated group at time points P14 and P29. The log2
expression values of 45,037 mRNA probe sets were
obtained after normalization using Partek Genomics Suite
Software. When the cut-off value of fold change was set as
> |2|, and the p-value for ANOVA analysis was set as
Figure 1 Effects of hyperoxia on neonatal mouse lung. Inflated lungs were paraffin embedded and five-micrometer tissue sections were
stained with hematoxylin and eosin (H&E). All pictures were taken at 200 x magnification. Calibration bar is 50 μm. (A) Exposure to room air at
postnatal day 14 (B) Exposure to hyperoxia at postnatal day 14 (C) Exposure to room air at postnatal day 29 (D) Exposure to hyperoxia at
postnatal day 29 (E) Mean linear intercept (F) Alveolar septal thickness (n = 11 mice/group; mean± SE, * p< 0.05 P14-O2 vs. P14-RA, ** p< 0.05
P29-O2 vs. P29-RA). (G) Relative mRNA expression of several biomarkers of BPD by RT-PCR comparing mouse lung exposed to room air with
hyperoxia (n = 3, mean± SE, # p< 0.05 vs. P14 room air controls, * p< 0.05 vs. P29 room air controls).
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< 0.05) to p< 0.018, 1904 significant probes were identified
for comparison Group A (P29-RA vs. P14-RA), 1386
probes for comparison Group B (P14-O2 vs. P14-RA) and
1961 probes for comparison Group C (P29-O2 vs. P29-RA),
suggesting discrete temporal patterns of gene expressionover the course of lung development and hyperoxia-
induced injury. In total, 2714 unique mRNAs were identi-
fied as hyperoxia-responsive genes from Group B and
Group C.
For each comparison group, we initially divided the
significant probes into two categories based on the
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However, as shown in Figure 2A, there was significant
overlap between the expression patterns of Groups B
and C, such that probes for these groups were divided
into six patterns: Pattern 3 and 4 were unique to Group
B; Pattern 5 and 6 were common to both Groups B and
C; and Pattern 7 and 8 were unique to Group C
(Figure 2A). We infer that the overlapping clusters may
contain transcripts of the genes most relevant to theFigure 2 Expression patterns of hyperoxia-responsive mRNAs and fun
confirmed. In total, 12 samples were used for analysis of mRNA expression;
P29; and 3 samples for each hyperoxia-treated group at time points P14 an
GeneChip Mouse Genome 430 2.0 Array. Expression patterns of hyperoxia-r
performed. (A) 8 expression patterns in 3 groups represented by color hea
indicating the relative expression value of group probes). Red represents in
depicted heat maps. The relative expression values in each time point are
vs P14-RA, Group B: P14-O2- treated vs P14-RA, Group C: P29-O2-treated vs
for 8 expression patterns. Top 10 GO terms (ranked by count number) withpathophysiology of BPD.Through the biological function
analysis of 8 distinct mRNA expression patterns using
the online biological classification tool DAVID, the top
10 gene ontology (GO) terms ranked by gene count
number with p< 0.05 were identified (Figure 2B). For
Group A, representing normal lung development across
two time points, genes with increased expression
(Pattern 1) were enriched with immune and inflamma-
tory response genes. Those with decreased expressionctional analysis. Total RNA was isolated and RNA quality was
2 samples for each normoxia group at time points of P1, P14, and
d P29. Gene expression profiling was performed using the Affymetrix
esponsive mRNAs and corresponding gene ontology mapping were
t maps and bar graphs (x axis indicating the 3 time points, y axis
creased expression and green represents decreased expression in the
the ratios normalized against those in the P1 group. Group A: P29-RA
P29-RA (B) Analysis of enrichment for GO biological process categories
p< 0.05 are listed.
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ity, adhesion and cell cycle. For both of Group B and C
which represent the hyperoxia-responsive genes, the
genes with increased expression (Pattern 3, 5 and 7)
were enriched for immune response and cell cycle, while
the genes with decreased expression (Pattern 4, 6 and 8)
were enriched in functions related with cell motility and
taxis.
Prolonged hyperoxia alters miRNA expression in the
neonatal mouse lung
To investigate dynamically regulated miRNAs as a con-
sequence of hyperoxia, miRNA expression profiling was
performed. We used the Taqman Rodent MicroRNA
array, which assays 521 mature mouse miRNAs based
on real-time PCR methodology. In total, 12 samples
were used for miRNA profiling, 2 samples for each nor-
moxia group at time points of P1, P14, and P29; and 3
samples for each hyperoxia-treated group at time points
P14 and P29. In all, 143 miRNAs were detected and
their values were normalized using small nuclear U6
RNA as an internal control. When the cut-off value of
fold change was set as> |4|, and the p-value was set as p
< 0.05 and further adjusted by FDR (FDR< 0.05) to p
< 0.027, we found 68 species which were dynamically
regulated. 7 of these occurred in Group A, 31 in Group
B and 64 in Group C.
For each comparison group, we initially divided the
significant miRNAs into two categories based on the
positive- and negative-fold changes in transcript levels.
In Group A, the expression values of four miRNA were
decreased (Pattern 1; miR-322*, miR-411, miR-431, miR-
609) and three were increased (Pattern 2; miR-146b,
miR-29a, miR-29c). As was the case with mRNA tran-
scription, there was significant overlap between the
miRNA expression patterns of Groups B and C, such
that miRNAs for these groups were divided into four
patterns (Figure 3A). Pattern 3 and 4 were unique to
Group B (increased miR-10b and decreased miR-680, re-
spectively); Pattern 5 was common to both Groups B
and C and contained 29 miRNAs whose expression was
increased; and Pattern 6 was comprised of 35 Group C
miRNAs whose expression was likewise increased.
Among the 7 miRNAs dynamically regulated over the
course of normal lung development (Group A), 5 of
these miRNAs (miR-411, miR-431, miR-699, miR-29a
and miR-29c) were up-regulated by oxygen exposure,
suggesting that prolonged hyperoxia alters the expres-
sion of miRNAs utilized during normal lung develop-
ment. Surprisingly, within 66 hyperoxia-responsive
miRNAs, all but one was up-regulated. The top 5 fold-
increased miRNA were miR-124 (450-fold), miR-706
(345-fold), miR-801 (171-fold), miR-685 (109-fold) and
miR- 494 (93-fold). The top 5 high expression valuemiRNAs were miR-709, miR-29a, miR-210, miR-810 and
miR-143; miR-709 was the most highly expressed with a
copy number of 23,676 per cell.
MiRNAs modulate mRNA expression in the neonatal
mouse lung exposed to hyperoxia
Given that miRNAs are known to negatively modulate
the level of “target” mRNAs, we considered individual
increased miRNAs as those potentially having mRNA
targets with decreased expression in our data. When
combined with computational prediction, simultaneous
profiling of miRNA and mRNA levels can be a strategy
for the identification of putative functional miRNA tar-
get mRNAs [25,26]. Two time points provide further in-
formation that could readily be missed in a cross-
sectional study based on a single time point [27]. For
this analysis, mRNA transcripts whose expression was
reduced in the O2 groups were considered as potential
targets for every individual miRNA whose expression
was simultaneously increased. We then cross-referenced
these potential mRNA targets against the computation-
ally predicted targets of the 66 hyperoxia-responsive
miRNAs from miRBase and TargetScan. In all, we iden-
tified 1303 miRNA-mRNA probe pairs, involving 581
unique mRNAs from miRBase, and 370 miRNA-mRNA
probe pairs which included 268 unique mRNAs from
TargetScan. In total, 152 mRNAs overlapped as targets
between the two databases (Figure 3B).
MiR-29 modulates development in the neonatal mouse
lung exposed to hyperoxia through Ntrk2
Expression of the MiR-29 family is increased during nor-
mal mouse lung development, and is known to play an
important role in the pathogenesis of lung diseases such
as pulmonary fibrosis [28,29]. Analysis of normal lung
has shown the presence of miR-29 in subsets of cells in
the alveolar wall and entrance to the alveolar duct [28].
In our miRNA array and real-time PCR data, miR-29a
and miR-29c were increased during normal lung devel-
opment, and expression was dramatically increased with
the induction of hyperoxia (Figure 4A). Based on
computational predictions from both miRBase and Tar-
getScan, there are a total of 25 predicted target mRNAs
for miR-29 within our data displaying decreased expres-
sion. We evaluated a number of these potential targets
through both quantitative real-time PCR and immuno-
histochemistry. We found neurotrophic tyrosine kinase
receptor type 2 (Ntrk2), glia maturation factor beta
(Gmfb), voltage-gated sodium channel (Scn3b) and high
mobility group box transcription factor 1 (Hbp1) expres-
sion all decreased significantly as identified in the array
data (Figure 4B). In particular, Ntrk2 mRNA and protein
expression in the hyperoxic lung was dramatically
decreased in comparison to mouse lung exposed to
Figure 3 Expression patterns of hyperoxia-responsive miRNA and miRNA targets. Total RNA was isolated and RNA quality confirmed. In
total, 12 samples were used for miRNA profiling, 2 samples for each normoxia group at time points of P1, P14, and P29; and 3 samples for each
hyperoxia-treated group at time points P14 and P29. MiRNA expression profiling was performed using the RT-PCR based Taqman Rodent
MicroRNA array measuring 521 mature mouse miRNAs. Raw miRNA array data were analyzed using RQ manager software. (A) 6 expression
patterns in 3 groups represented by color heat maps. (B) MiRNA expression and prediction of miRNA targets. Average miRNA expression is
shown as copy number. Predicted targets indicate miRNA targets identified by overlapping computationally predicted mRNA targets with the
mRNAs having opposite expression patterns with their corresponding individual miRNAs in our data. When two mature miRNAs originate from
opposite arms of the same pre- miRNA, they are denoted with a -3p or -5p suffix. When relative expression levels are known, an asterisk
following the name indicates a miRNA expressed at low levels relative to the miRNA in the opposite arm of a hairpin, for example, miR-322 and
miR-322* would share a pre-miRNA hairpin, but more miR-322 would be found in the cell [24].
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Figure 4 Effects of hyperoxia on the expression of miR-29 and predicted mRNA targets. (A) Relative expression of miR-29a and miR-29c
(n = 3, mean± SE, # p< 0.05 vs. P14 room air controls, * p< 0.05 vs. P29 room air controls). (B) Relative mRNA expression by RT-PCR comparing
mouse lung exposed to room air with hyperoxia (n = 3, mean± SE, # p< 0.05 vs. P14 room air controls, * p< 0.05 vs. P29 room air controls). (C)
Nrtk2 protein expression measured by Western blot analysis using β-actin as the loading control (n = 3, mean± SE, # p< 0.05 vs. P14 room air
controls, * p< 0.05 vs. P29 room air controls). Protein expression of Nrtk2 in the lung of P14-RA (D), P14-O2-treated (E), P29-RA (F) and P29-O2-
treated mice (G). Nrtk2 immunoreactivity was detected in brown. (H) and (I) Immunohistochemical localization of Nrtk2 in P29-RA lung. Red
arrow indicates bronchiolar epithelial cells, green arrow indicates type II pneumocyte, blue indicates endothelial cells and black indicates
macrophage.
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and density for Ntrk2 was also significantly decreased in
the lung exposed to hyperoxia (Figure 4D-G). We
observed expression of Ntrk2 distributed around small
bronchioles and scattered within the alveolar wall in
normal lung, consistent with previous reports that Ntrk2
is expressed in epithelial cells of bronchioles, type II
pneumocytes and macrophages (Figure 4H-I) [30].
MiR-29 modulates predicted target mRNAs in mouse
bronchoalveolar stem cells (BASCs)
To investigate direct targets of miR-29, we identified candi-
date mRNAs by overlapping computational prediction with
opposite expression patterns in our miRNA and mRNA
data. MiR-29 was then overexpressed in vitro by transfec-
tion of miR-29a and miR-29c mimics into bronchoalveolar
stem cells (BASC), isolated and cultured in our laboratory
as previously described [31]. BASC cells are located in the
bronchoalveolar duct junction, populate the Type I and
Type II pneumocyte and Clara cell niches, and are thought
to regenerate both bronchiolar and alveolar epithelium dur-
ing homeostatic turnover and in response to injury [32].
After 24 hours following transfection, mRNAs were isolated
and miR-29 expression measured by RT- PCR. We
observed a limited degree of coincident expression
increases of either miR-29a or miR-29c after transfection of
respective miR-29a or miR-29c mimics (Additional file 1:
Figure S1). This phenomenon can likely be explained by
the one base pair difference in their respective sequence
[33]. After overexpression of miR-29 was confirmed, we
examined mRNA expression for 23 of 25 predicted target
genes, excluding 2 with no defined function. All mRNAs
except Gmfb, were decreased in expression (Additional file
2: Table S5), including 12 of 23 target genes significantly
decreased more than 50% (Figure 5). Ntrk2 mRNA expres-
sion was decreased by 43% and 44% (n=3, p< 0.05) after
transfection of miR-29a and miR-29c respectively.
Hyperoxia alters the expression of genes which regulate
multiple biological processes
Given the large number of dynamically expressed genes in
the hyperoxia groups, we sought to organize the expression
data on the basis of biological processes. We employed
DAVID to classify the significant hyperoxia-responsive
mRNAs into functionally related clusters. In all, 2714
mRNA probes from Groups B and C were entered as input.
Classification Stringency was set as “Medium”, using cri-
teria p< 0.05, FDR< 0.05. We identified 6 functional clus-
ters among these transcripts (Enrichment Score> 6.89):
cell cycle; cell adhesion; cell mobility and migration; cell
taxis and response to external stimulus; vascular develop-
ment and angiogenesis; and stress and inflammation (Add-
itional file 3: Table S1). Within these 6 functions, a total of
499 genes were identified to be involved. Additional file 4:Table S2 contains a list of these genes, including title;
symbol ID; biological function; fold-change direction; time
change point and, in the case of genes with decreased ex-
pression, the corresponding miRNA predicted to regulate
the transcript.
Individual miRNAs may target multiple mRNAs, and
individual genes may be regulated by a number of miR-
NAs or multiple members of the same miRNA family.
Groups of miRNAs which change in specific biological
conditions have predicted propensity to target genes
with relative functions which can provide insight into
the biological roles of miRNAs [34,35]. To explore if
there was a difference in biological function between
miRNA-regulated hyperoxia- responsive genes and non-
miRNA-regulated hyperoxia-responsive genes, we com-
pared the GO process term enrichment between the two
groups using the MetaCore enrichment analysis tool.
Figure 6 shows the distribution histogram of the most
enriched 10 GO process terms as sorted by “differen-
tially affected maps,” which lists terms in decreasing
order of the standard deviation of the -log (p-Value) be-
tween the two groups. Thus, the top terms represented
by this histogram would have the largest absolute differ-
ence in their strip lengths, indicating the GO process
term enrichment of the two groups is significantly differ-
ent. As shown in Figure 6, miRNA-regulated genes (blue
strip) more often were enriched in the term immune
system process than were non- miRNA-regulated genes
(red strip). Genes not regulated by miRNAs were more
often enriched in all other functional categories, most
notably response to stress, locomotion, and cell motility.
Overlap of dynamically regulated miRNAs in normal lung
alveolar development and hyperoxia-induced BPD
MiRNAs play an important role during mouse lung de-
velopment. Recent work by our group demonstrated that
117 significant miRNAs were dynamically regulated dur-
ing mouse lung organogenesis from 7 time points com-
passing all recognized stages of lung development
beginning at embryonic day 12 and continuing to adult-
hood [11]. Among the 66 miRNAs identified from the
O2-treated group in this study, 33 miRNAs overlapped
with the 117 miRNA identified during lung organogen-
esis from our previous study, suggesting that prolonged
hyperoxia may interrupt the dynamic expression of miR-
NAs involved in normal lung development (Additional
file 5: Table S3). This observation provides further evi-
dence for the potential characterization of BPD as an ar-
rest of normal pulmonary alveolar development.
Discussion
The network of miRNA-mRNA interactions in animal
models of BPD has not been described and remains
poorly understood. We explored the dynamic regulation
Figure 5 Validation of predicted miR-29 targets. Total mRNA were isolated after 24 hours transfection of BASC cells with miR-29a mimic,
miR29c mimic and non-specific miRNA-negative control. MiR-29a and miR-29c overexpression were confirmed by real-time PCR (Additional file 1:
Figure S1). Relative gene expression of predicted target mRNAs decreased more than 50% in BASC cells are shown (n = 3, mean± SE, # p< 0.05
miR-29a vs. miR-negative control, * p< 0.05 miR-29c vs. miR-negative control). Results are from real-time PCR with β-Actin as a housekeeping
control.
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development under 80% O2-treatment through genome-
wide mRNA expression and real-time PCR based
miRNA profiling. From our miRNA array profile, strik-
ingly, 65 of 66 dynamically regulated miRNAs were
increased in expression; only one was decreased, sug-
gesting that increased miRNA expression may contribute
to the down-regulation of key genes necessary for nor-
mal alveolar development to proceed. Given that miR-
NAs regulate the cleavage of targeted mRNAs, we
focused on negatively regulated hyperoxia-responsive
genes to identify potential targets of miRNAs. After
combining these potential targets with computational
prediction, 581 unique mRNAs were identified as targets
of miRNAs using miRBase, suggesting that miRNAs
regulated 53% of all repressed hyperoxia-regulated genes
in our dataset. While these correlations do not inferFigure 6 Biologic function of miRNA-regulated genes under hyperoxi
and non-miRNA-regulated genes under hyperoxia was compared using the
terms were sorted by the “differentially affected maps”, and sorted in decre
the two groups. The bar in blue colour represents the GO process term en
colour for the group of non-miRNA-regulated genes.direct causality, they nonetheless suggest a significant
contribution of miRNA-based regulation of gene expres-
sion to the alterations observed in this mouse model of
BPD. By GO biological process term enrichment ana-
lysis, in contrast with non-miRNA-regulated genes,
miRNA-regulated genes were particularly enriched for
the GO term “immune system process”. Immune system
dysfunction has been postulated as a contributing factor
in the pathophysiology of BPD, as imbalances of “pro-
inflammatory" and "anti-inflammatory" cytokines and
impairment in the transition from the innate immune
response mediated by neutrophils to the adaptive im-
mune response mediated by T lymphocytes has been
described [36]. We validated a number of our
microarray-based observations using real-time PCR
and immunohistochemistry. Interestingly, we observed
increased expression of miR29c in conjunction witha. Gene ontology process term enrichment between miRNA-regulated
MetaCore enrichment analysis tool. Top 10 GO process enrichment
asing order of the standard deviation of the -log (p-Value) between
richment for the group of miRNA-regulated genes and the bar in red
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Ntrk2. In normal lung, Ntrk2 protein by IHC was
found to be located within the alveolar wall and
around small bronchioles, consistent with previous
reports [30]. In response to hyperoxia, we observed a
similar distribution but dramatically decreased staining
and protein expression for Ntrk2. Ntrk2 is essential for
the normal development of the lung, as transgenic de-
letion results in thinned out bronchial epithelium and
larger alveolar air spaces, a phenotype strikingly similar
to that observed in our mouse BPD model [30].
Downregulated Ntrk2 expression, regulated by miR-
29c, may play an important role for the development
of hyperoxia-induced bronchopulmonary dysplasia and
clearly represents an avenue for further research. A
number of genes identified as predicted miR-29 targets
were also validated in a miR-29 overexpression model
using BASC cells. For this specific cell type in vitro,
one of many in the developing lung, miR-29 was
shown to directly modulate expression of predicted
target mRNAs. The influence of specific lung cell types
on predicted miRNA-mRNA interactions relevant to
the pathophysiology of BPD awaits further
investigation.
Through GO biological process term enrichment ana-
lysis, we found hyperoxia-responsive genes mainly
involved in six biological functional groups including cell
cycle, motility, adhesion, taxis, angiogenesis and inflam-
mation. Cell cycle plays an essential role for cell prolif-
eration and further lung organogenesis. p21, a critical
inhibitor of the cell cycle, is up-regulated in hyperoxia-
induced mouse and baboon models of BPD and oxidative
stress [37,38]. In our study, p21 and other cell cycle inhibi-
tors, including many Cyclin (Ccn) and Cell division cycle
(Cdc) family members, were ignificantly up-regulated.
Several growth factor expressions were found to be up-
regulated in our data, such as TGF-β2, IGF, platelet-derived
growth factor (PDGF) and connective tissue growth factor
(CTGF), TGF-β signaling can negatively regulate the
branching and septation phases of lung development.
Adenoviral-mediated transfer of TGF-β o the neonatal
rat lung or overexpression of TGF- β between postnatal
day 7 and day 14 in the mouse can induce histological
changes analogous to those seen in BPD [19,39]. VEGF
and platelet-endothelial cell adhesion molecule-1
PECAM1) have been reported to promote pulmonary
vascular development [40,41], and down-regulated ex-
pression of VEGF-A and PECAM1 have been reported
in the neonatal lung with severe BPD [42]. In our data,
VEGF, ECAM1 and numerous genes involved in angiogen-
esis were down-regulated, as well as angiogenic signaling
mediators PI3K, p85 and Akt-1. Among these genes, our
data suggest that the expression of PECAM1 was regulated
by let-7i, miR-322 and miR-497, and the expression of VE-cadherin and β-cadherin regulated by miR-27a.In summary,
we describe the dynamic regulation of gene and miRNA ex-
pression in a hyperoxia-induced model of BPD in the
mouse. The abnormal alveolar development observed is
accompanied by significant increases in the levels of
multiple miRNAs and corresponding decreases in the
levels of predicted mRNA targets, many of which have
known or uspected roles in pathways altered in BPD.
The data also suggest that BPD is a multifactorial dis-
order characterized by multiple pathway defects as
opposed to one overriding abnormality. What the incit-
ing triggers are for the initiation of BPD, how these ab-
normalities are maintained, and how this relates to
normal alveolar development will clearly require a
systems-based approach using genetically tractable
model organisms such as the mouse. The results overall
suggest that the dynamic regulation of miRNAs and the
subsequent downstream target effects on mRNA and
protein expression may play a prominent role in the
pathophysiology of BPD.
Conclusions
In newborn mice, prolonged hyperoxia induces an arrest
of alveolar development similar to that seen in human
neonates with BPD. This abnormal lung development is
accompanied by significant increases in the levels of
multiple miRNAs and corresponding decreases in the
levels of predicted mRNA targets, many of which have
known or suspected roles in pathways altered in BPD.
These data support the hypothesis that dynamic regula-




Approval of the study protocol was obtained from the
Mayo Clinic Institutional Animal Care and Use Commit-
tee with protocol number A41708. All experiments were
carried out according to the provisions of the Animal
Welfare Act, the tenets of the Public Health Service Pol-
icy on Humane Care and Use of Laboratory Animals, and
the principles of the National Institutes of Health Guide
for the Care and Use of Laboratory Animals. Time-
pregnant ICR mice were maintained on an ad libitum
diet of standard chow and water. Within 12 hours of
birth, ups were pooled and then randomized into four
experimental groups. Mice were exposed to hyperoxic
(80% oxygen) or room air (21% oxygen) conditions for ei-
ther 14 or 29 days. The hyperoxic environment was
established by ventilating a Plexiglas chamber (approxi-
mately 100 × 50 × 50 cm) with 3.5 L/min pure oxygen.
Oxygen levels were continuously monitored with a
Miniox III monitor, and carbon dioxide levels were spot-
checked at the outset to ensure normal ambient carbon
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http://www.biomedcentral.com/1471-2164/13/204dioxide levels within the chamber. Room air-exposed
mice were housed in standard cages. Nursing dams were
rotated between exposure groups every 24 hours to pre-
vent oxygen toxicity in the dams and to mitigate maternal
effects between the experimental groups.
Preparation of lung tissue
Mice were exposed to 80% or 21% O2 for 14 days or
29 days. Body weights were recorded and mice were
sacrificed by CO2 narcosis at the end of the exposure
period. In half of the animals within each group, lungs
were immediately inflated to 20 cm H2O pressure with
10% buffered formalin. After overnight fixation, the
inflated lungs were paraffin embedded and 5 μm tissue
sections were stained with hematoxylin and eosin
(H&E). Alveolar morphology was assessed by measuring
mean linear intercept (MLI) and alveolar septal thickness
(AST) on H&Estained slides using standard imaging
techniques [43]. For the remaining animals, lungs were
removed and immediately frozen and stored in liquid ni-
trogen for further use.
MicroRNA and gene expression analysis
Total RNA was isolated using Trizol Reagent (Invitro-
gen) and the mir VanaTM miRNA Isolation kit
(Ambion) for mRNA and miRNA microarray analysis
according to manufacturer’s instructions. RNA quality
and integrity were confirmed by denaturing gel electro-
phoresis. In total, 12 samples were used for mRNA and
miRNA profiling respectively; 2 samples for each nor-
moxia group at time points of P1, P14, and P29; and 3
samples for each hyperoxia-treated group at time points
P14 and P29. Messenger RNA expression profiling was
performed using the Affymetrix GeneChip Mouse Gen-
ome 430 2.0 Array containing probes to query more
than 45,000 transcripts. The reverse transcription, label-
ing and hybridization of mRNA were performed in the
Mayo Clinic Advanced Genomic Technology Center.
MiRNA expression profiling was performed using the
Taqman Rodent MicroRNA Array Card A and Card B
(Applied Biosystems) containing all 521 mature mouse
miRNA in miRBase 10.1 http://microrna.sanger.ac.uk
based on real-time PCR methodology. In brief, miRNA
was reverse transcribed to cDNA using the Megaplex
TM RT Rodent Primers Pool and the TaqMan Micro-
RNA Reverse Transcription kit. Quantitative 384 well
TaqMan Low Density Array real- time PCR was run on
the ABI PRISM 7900 System using TaqMan Universal
PCR Master Mix. Raw miRNA array data were analyzed
using the RQ manager software on the ABI System. All
undetectable data or data with CT values >35 were trea-
ted as 35 according to standard protocols [44]. For each
miRNA, a normalized CT value (ΔCT) was calculated by
comparing each miRNA value to that of small nuclearU6 RNA, a common internal control in microRNA
arrays. The copy number per cell of each miRNA then
was determined, assuming that each cell contains 30 pg
total RNA and using the accepted formula: 10(40-CT)/3.34/
22 [45].
All microarray data have been submitted to the Gene
Expression Omnibus (GEO) database with accession
number GSE25286 for mRNA expression array and
GSE25290 for miRNA array.
Data processing and analysis
Both the miRNA and the mRNA array data were ana-
lyzed using the Partek Genomics Suite 6.4 software. For
mRNA expression data, Affymetrix CEL files were
imported. The data were normalized with the Robust
Multichip Average Algorithm [46] and converted to log2
values. For miRNA data, ΔCT values were directly
imported as log2 values. Greater ΔCT values were inter-
preted as lower miRNA expression values. Logarithmic
data were used for further statistical analysis. After elim-
inating genes with low expression levels in all time
points, fold change and the False Discovery Rate (FDR)
adjusted p-values derived from two-way ANOVA ana-
lysis were used to filter out significantly changed miRNA
and mRNA probes. The False Discovery Rate (FDR) of a
set of predictions is the expected percent of false predic-
tions in the full set of predictions.Hyperoxia-responsive
miRNA and mRNA probes were divided into 3 different
groups according to the interactions between 2 time
points (P14 vs. P29) and two types of treatment (O2 vs
RA). Group A compared Day 14 and Day 29 RA mice;
Group B compared O2 and RA mice at Day 14; and
Group C compared O2 and RA mice at Day 29. The
comparison of O2-treated mice at 14 and 29 days
revealed all mRNA and miRNA expression changes to
be present in either groups B or C; as a consequence we
did not analyze this group further. Within each group,
data was divided into positive- and negative-fold change
values that were visualized on the heat map produced by
dChip software (www.dchip.org). We assumed that an
individual upregulated miRNA would have potential
mRNA targets with downregulated expression in the
same group. Overlapping these potential targets with the
computational mRNA targets of each miRNA retrieved
from the miRBase (version 5) and TargetScanMouse
(5.1) databases, we identified a collection of direct
mRNA targets for each miRNA. The software package g:
Profiler was used to convert Transcript IDs from miR-
Base into Affymetrix mouse 430 probe set IDs [47].
Gene ontology and pathway analysis
Gene Ontology (GO) provides a structured ontology of
defined terms representing putative functional properties of
specific gene products. Using whole probe sets from the
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enrichment analysis was performed using the Database for
Annotation, Visualization and Integrated Discovery
(DAVID, National Institutes of Health) [48]. Functional dif-
ferences between miRNA-regulated or non-miRNA-
regulated genes were investigated using the Compare
Experiments workflow tool (MetaCore).
Quantitative real-time PCR
After reverse-transcription (Invitrogen), absolute quanti-
tative real-time was performed using Brilliant SYBR
Green QPCR Master Mix (Stratagene) and the PRISM
7900 system (Applied Biosystems) according to the man-
ufacturer’s instructions. After PCR, melting curves were
constructed to ensure elimination of nonspecific pro-
ducts. The amount of mRNA was determined by
comparing with the standard curves and normalization
by β-Actin. The primer sequences utilized are listed in
Additional file 6: Table S4.
Western blot analysis
Immunologic detection of Ntrk2 with rabbit polyclonal
Ntrk2 antibody (Abcam, ab33655, 1:500 dilution) was per-
formed. In brief, 20 μg total protein was loaded on a 6%
polyacrylamide gel, electrophoresed, and transferred to
polyvinylidene diflouride membranes, which were blocked
with Tween-Tris buffered salt solution (TTBS) containing
5% skim milk. Membranes with incubated overnight at 40
with Ntrk2 antibody. After washing 3 times with TTBS,
membranes were incubated with anti-rabbit-IgG-HRP for
1 hour at room temperature and images recorded. β-actin
was used as loading control.
Immunohistochemistry
Ntrk2 immunohistochemistry was performed using stand-
ard protocols. In brief, primary anti-Ntrk2 antibody
(Abcam, ab33655) diluted 1:200 in the blocking buffer was
applied to 10 um thick mouse lung sections and incubated
for 30 min. After the slides were rinsed and incubated with
the peroxidase-labeled, polymer-conjugated goat anti-rabbit
secondary antibody, the labeled structure was visualized.
Transfection of miR-29 mimics
SiPORT NeoFx Transfection Agent (Ambion) was used to
deliver miRNA mimics (small duplex RNAs) into BASC
cells according to the manufacturer’s instructions. Cells
were plated in six-well dishes at density of 120,000 cells/
well. MiRNA mimics including miR-29a mimic, miR-29c
mimic and miRNA mimic negative control (Applied Bio-
systems) were transfected respectively at the final concen-
tration of 25 nM. The sequence for the miR-29a mimic is
UAGCACCAUCUGAAAUCGGUUA; for the miR-29c
mimic UAGCACCAUUUGAAAUCGGUUA. After
24 hours post-transfection, miRNAs were isolated using themirVanaTM miRNA Isolation kit. The overexpression of
miR-29a and miR-29c were confirmed by Real-time based
TaqMan MicroRNA Assay (Applied Biosystems). MiRNA
expression levels relative to SnoRNA-202 (internal control)
were calculated on the basis of ΔΔCt methods. The n-fold
change in miRNAs expression was determined according
to the method of 2−ΔΔCT.
Additional Files
Additional file 1: Figure S1. Relative miR-29 expression in BASC cells
after transfection of miR-29 mimics.
Additional file 2: Table S5. MiR-29 targeted gene expression in BASC
cells following transfection with miR-29 mimics.
Additional file 3: Table S1. Identification of functionally related clusters
in hyperoxia-induced BPD. All 2714 mRNA probes which significantly
changed under hyperoxia were classified into functionally related clusters
using DAVID. The 6 top functionally related clusters including cell cycle,
adhesion, mobility, angiogenesis, taxis, and inflammation are listed.
Additional file 4: Table S2. List of hyperoxia-responsive genes involved
in functional categories of cell cycle, adhesion, mobility, migration,
angiogenesis, taxis and inflammation. Potential miRNAs involved in
regulation of these functions are also listed.
Additional file 5: Table S3. Overlap of dynamically regulated miRNAs
in normal lung alveolar development and hyperoxia-induced BPD.
Among 66 miRNAs identified from O2-induced BPD, 33 miRNAs
overlapped with the 117 miRNA identified as dynamically regulated
during lung organogenesis. The expressed copy number values of all 117
miRNA are listed.
Additional file 6: Table S4. Primer sequences for real-time PCR.
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